ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

TYRA Tyra Biosciences Inc

18,85
0,35 (1,89%)
Zuletzt aktualisiert: 21:15:38
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Tyra Biosciences Inc TYRA NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,35 1,89% 18,85 21:15:38
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
18,80 16,88 19,39 18,50
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
09.5.202422:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09.5.202422:46EDGAR2Form 3 - Initial statement of beneficial ownership of..
09.5.202422:12EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09.5.202422:08EDGAR2Form 8-K - Current report
09.5.202422:05PRNUSTyra Biosciences Reports First Quarter 2024 Financial..
07.5.202422:34EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
07.5.202422:29EDGAR2Form 8-K - Current report
07.5.202422:05PRNUSTyra Biosciences Announces Appointments of Susan Moran,..
19.3.202421:05PRNUSTyra Biosciences Reports Fourth Quarter and Full Year 2023..
08.3.202423:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.3.202423:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.3.202400:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27.2.202422:05PRNUSTyra Biosciences to Present at Upcoming Investor Conferences
15.2.202403:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.2.202422:36EDGAR2Form D - Notice of Exempt Offering of Securities
12.2.202422:46EDGAR2Form 144 - Report of proposed sale of securities
10.2.202401:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.2.202422:05PRNUSTyra Biosciences to Present at Oppenheimer's 34th Annual..
07.2.202402:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.2.202422:56EDGAR2Form 144 - Report of proposed sale of securities
05.2.202412:05EDGAR2Form 8-K - Current report
02.2.202423:04EDGAR2Form 144 - Report of proposed sale of securities
02.2.202414:00PRNUSTyra Biosciences, Inc. Announces $200 Million Private..
01.2.202423:30PRNUSTyra Biosciences Receives FDA Rare Pediatric Disease..
01.2.202423:24EDGAR2Form 8-K - Current report
22.12.202315:00EDGAR2Form 8-K - Current report
22.12.202315:00PRNUSTyra Biosciences Doses First Patient with TYRA-200 and..
08.11.202322:05PRNUSTyra Biosciences to Participate in 2023 Jefferies London..
07.11.202322:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07.11.202322:07EDGAR2Form 8-K - Current report
07.11.202322:05PRNUSTyra Biosciences Reports Third Quarter 2023 Financial..
26.10.202322:50EDGAR2Form 8-K - Current report
21.9.202314:00PRNUSTyra Biosciences Announces Oral Presentations on TYRA-300..
20.9.202301:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12.9.202322:05PRNUSTyra Biosciences to Participate at 2023 Cantor Global..
10.8.202322:27EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10.8.202322:21EDGAR2Form 8-K - Current report
10.8.202322:05PRNUSTyra Biosciences Reports Second Quarter 2023 Financial..
01.8.202323:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.8.202323:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.8.202314:54DJNTyra Biosciences Gets FDA Orphan Designation for TYRA-300 in..
01.8.202314:00PRNUSTyra Biosciences Announces FDA Orphan Drug Designation for..
22.7.202302:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18.7.202301:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.7.202300:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.7.202323:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.6.202302:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25.5.202314:00PRNUSTyra Biosciences to Participate in Upcoming Investor..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock